Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GWP42006 in focal seizures
NCT02365610Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of cannabidivarin in focal seizures, sponsored by Jazz Pharmaceuticals plc. Started Mar 2016; status: completed.
02
Drugs
cannabidivarin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT02365610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365610.